eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | systemic scleroderma |
| Comorbidity | C0034069|lung fibrosis |
| Sentences | 6 |
| PubMedID- 20962569 | Proteome analysis of bronchoalveolar lavage fluid in lung fibrosis associated with systemic sclerosis. |
| PubMedID- 24442885 | Objectives: to assess the effects of rituximab (rtx) on skin and lung fibrosis in patients with systemic sclerosis (ssc) belonging to the european scleroderma trial and research (eustar) cohort and using a nested case-control design. |
| PubMedID- 25371756 | Blood-patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: a case report. |
| PubMedID- 25096855 | Autoantibodies against endothelin-1 type a receptor (etar) are present in systemic sclerosis complicated by lung fibrosis and pulmonary hypertension. |
| PubMedID- 21454805 | Wnt/beta-catenin signaling is important in normal lung development, but whether abnormal signaling occurs in lung fibrosis due to systemic sclerosis and the consequences of beta-catenin signaling toward the fibrogenic phenotype remain poorly defined. |
| PubMedID- 20544245 | The association of cyclophosphamide (cyc) and prednisone (pred) for the treatment of lung fibrosis in systemic sclerosis (ssc) was only evaluated in uncontrolled studies, although in idiopathic interstitial lung disease (ild) this association seems to be beneficial in patients with non-specific interstitial pneumonia (nsip). |
Page: 1